Dr. Becher and the NOAH—AFNET 6 team evaluated the efficacy and safety of anticoagulation with edoxaban in patients with long episodes of device-detected atrial fibrillation lasting 24 hours or ...

More information: Paulus Kirchhof et al, Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials ...

The annual risk of recurrent ischemic stroke in patients with atrial fibrillation (AF) is about 3.75%, despite around 92% of ...

In this randomized trial, left atrial appendage closure was associated with lower bleeding than oral anticoagulation in ...

I've been diagnosed with atrial fibrillation. I've read that it puts me at greater risk of stroke. Can you tell me more about ...

There is an apparent underuse of warfarin in elderly patients with AF, as there is inconsistency in opinion among clinicians about who should receive anticoagulation. The risks of warfarin are ...

Warfarin reduces the risk of stroke in atrial fibrillation by around 60%, while antiplatelet therapy is much less effective. Bleeding is, however, a notable adverse effect with warfarin.

Data show early anticoagulation after acute stroke in people with atrial fibrillation is safe when indicated. Risk for recurrent ischemic stroke at 30 days was lower in the early vs. late ...

Atrial fibrillation, also called AF or AFib ... Alcohol Leafy green vegetables, which can interfere with warfarin Foods that have a lot of salt Processed foods that have a lot of added ...

Objective: To evaluate data addressing use of anticoagulation in elderly patients with atrial fibrillation (AF), in particular those at risk of falls. Data Sources: Primary literature was ...